iStock-172360724_web.jpg
iStock-530185374_web.jpg
iStock-583818478_web.jpg
iStock-496261146_web.jpg
iStock-172360724_web.jpg

Nanovehicles for SAFER MEDICATIONS


From development to commercialization. 
See how we do it. 

SCROLL DOWN

Nanovehicles for SAFER MEDICATIONS


From development to commercialization. 
See how we do it. 

SOVIGO is a drug delivery company focused on the development of nanoparticle-based systems to improve the therapeutic effectiveness of drugs, with an initial focus on the treatment of selected gastro-intestinal diseases. 

iStock-530185374_web.jpg

What we do


What we do


 

Our primary goal is to achieve specific delivery of drugs to the site of disease without affecting healthy cells in the body which can reduce adverse drug reactions and improve clinical outcomes.

 
iStock-583818478_web.jpg

Why we do it


Why we do it


Because we believe that for every problem...

Many drugs, have unacceptable side effects due to the drug interacting with healthy tissues that are not the target of the drug. This significantly limits the ability to design optimal medications for many diseases and negatively impacts patient's adherence to therapies. Therefore innovative drug delivery systems that control the rate at which a drug is released and the location in the body where it is released are needed.

...there is a solution...

Sovigo engages in the development of oral drug delivery system based on submicroscopic particles composed of biodegradable molecules called lipids.  Due to their nanosize and engineered surface chemistry, these  particles have the potential not only to decrease systemic side effects and improve therapeutic efficacy but also augment drug concentration at the disease target site.

...WHICH can improve quality of life

We believe that these attributes can improve patient compliance toward treatment hence improving clinical outcomes and provide competitive differentiation for pharmaceuticals and enabling new therapies with entirely unique properties.

iStock-496261146_web.jpg

Who we are


Who we are


grzegorz kielbowicz

PhD, Founder

Grzegorz has a long-standing scientific background in biotechnology and chemistry with a Ph.D. degree in biological sciences. He is specializing in chemo-enzymatic modification of lipids and their applications as delivery systems of active ingredients. He has gained an extensive industry experience cooperating with pharmaceutical and medical technology companies.

Pawel Mitula

PhD, Founder

Pawel is a Biotechnologist with a passion for chemistry and technological processes. He has a Ph.D. in biological sciences and multiple years of chemical industry experience. His interests include methods for improving bioavailability of active compounds and application of smart drug delivery systems.

Contact us


Contact us


Thanks for visiting  SOVIGO! For general questions or inquiries, please complete the form below. We look forward to hearing from you.

SOVIGO
Klecinska 123 (Wroclaw Technology Park) 
54-424 Wroclaw, Poland